Additionally, we measured p53-promoter activity in an SH-SY5Y neuroblastoma cell line stably overexpressing parkin (Parkin-SY5Y cells), and found that p53 promoter activity was decreased 68% compared to the control (Figure 1C). The gene discussed is PRKN; the disease is neuroblastoma.